IEC 60601-2-23:2011

Overview

IEC 60601-2-23:2011 is an international standard published by the International Electrotechnical Commission (IEC) specifying the basic safety and essential performance requirements for medical electrical equipment used in transcutaneous partial pressure monitoring. This particular standard focuses on transcutaneous monitors that measure the partial pressure of gases such as oxygen and carbon dioxide through the skin.

The scope includes devices used with adults, children, neonates, and extends to fetal monitoring during childbirth. Notably, this standard excludes haemoglobin saturation oximeters and devices applied on non-skin surfaces like conjunctiva or mucosa.

This third edition (2011) revises and replaces the 1999 edition, aligning the requirements structurally with the 2005 edition of IEC 60601-1, which covers general safety and performance requirements for medical electrical equipment.

Key Topics

• Basic safety requirements: Covering protection against electrical, mechanical, radiation, and temperature hazards related to transcutaneous partial pressure monitors.
• Essential performance criteria: Ensuring accuracy, reliability, and consistent performance of transcutaneous gas monitoring.
• Testing requirements: Normative references for verification of equipment functionality, including measurements, calibration, and performance under fault conditions.
• Alarm systems: Requirements and guidance on alarm functionality to alert caregivers to abnormal or hazardous conditions.
• Electromagnetic compatibility (EMC): Ensuring devices can operate safely in medical environments without interference from or causing electromagnetic disturbances.
• Marking and documentation: Guidelines for clear, unambiguous labeling and user instructions essential for safe operation and maintenance.
• Programmable electrical medical systems (PEMS): Specific considerations for software and programmable components within monitoring equipment.
• Use across patient populations: Applicability to adults, children, neonates, and fetal monitoring during labor.

Applications

IEC 60601-2-23:2011 applies to manufacturers, designers, testing laboratories, and healthcare facilities involved in:

• Development and certification of transcutaneous partial pressure monitors.
• Use of these monitors in clinical settings, including intensive care units, neonatal care, and labor and delivery wards.
• Ensuring devices meet internationally recognized safety standards for accurate monitoring of oxygen and carbon dioxide partial pressures transcutaneously.
• Supporting clinical decision-making in respiratory and metabolic monitoring by providing reliable non-invasive measurements.
• Facilitating regulatory approvals and market access by adhering to standardized technical and safety requirements.

Related Standards

• IEC 60601-1 (2005 edition) - General requirements for basic safety and essential performance of medical electrical equipment.
• Other parts of the IEC 60601 series covering specific medical electrical devices.
• Standards related to electromagnetic compatibility for medical devices.
• Guidance on alarm systems per IEC 60601-1-8 which is closely referenced for alarm functionality in transcutaneous monitors.
• International standards on risk management and software lifecycle processes relevant to programmable medical systems integrating with transcutaneous monitors.

Practical Value

Complying with IEC 60601-2-23:2011 ensures that transcutaneous partial pressure monitoring equipment is:

• Safe for use on vulnerable patient populations including neonates and fetuses.
• Correctly calibrated to provide accurate readings needed for critical clinical decisions.
• Equipped with robust alarm systems to promptly notify caregivers of hazardous conditions.
• Resistant to unintended electromagnetic interference, preventing malfunctions in clinical environments.
• Properly documented and labeled for user comprehension, facilitating safe device operation and maintenance.

Healthcare providers and manufacturers prioritizing adherence to this standard demonstrate commitment to delivering high-quality, reliable, and safe transcutaneous monitoring solutions aligned with globally recognized best practices.